Subscribe
Logo small
Search

Pharmacotherapy in SMA is a breakthrough in the lives of patients

MedExpress Team

Piotr Wójcik

Published Nov. 7, 2022 09:39

Pharmacotherapy in SMA is a breakthrough in the lives of patients - Header image
- We can say that not only have the natural course of SMA, which is a progressive disease untreated, been reversed. So the stabilization of the patient's condition would be a huge success. We can see, however, that the condition of our patients is improving - said Prof. Anna Kostera-Pruszczyk, head of the Department and Clinic of Neurology, UCK WUM.

You are the co-author of the report "Spinal Muscular Atrophy and SMA Treatment in Poland. New quality of life for patients and carers ”. What are the conclusions of this report?

The most important conclusion from the report on the treatment of patients with spinal muscular atrophy in Poland is that during these few years we have managed to extend the treatment to a very large population of patients of all ages, from children to adults, including presymptomatic patients. What is our greatest joy today is that we see the effectiveness of this therapy in all patients. Not a single patient was excluded from the program due to loss of efficacy. This is a very important argument for treating all patients and seeing their next success...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Lub znajdź wyjątkowe miejsce pracy!

Read also